Clinical trial
SAPIEN 3 Ultra EU Post-Market Observational Study
NCT04860752 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SAPIEN 3 Ultra EU Post-Market Observational Study
- Lead sponsor
- Edwards Lifesciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2021
- Completion date
- July 22, 2024
- Enrollment
- 500 (actual)
- Sites
- 37
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis, aortic valve stenosis